“…In the early phases of the pandemic, there were serious concerns that aerosol therapy, especially nebulization, was an AGP and its use could enhance viral transmission and pose a risk to health care workers. 54 Two clinical studies, 47,55 one healthy volunteer study 30 and one in vitro study, 56 reported that aerosol particle concentrations, particularly in small aerosol particles (# 5 mm), in the ambient air increased by $100 times with nebulization (Table 4). Using the smoke light detection technology, Hui et al also reported greater smoke dispersion distances with a small-volume nebulizer (SVN) driven by 6 L/min air than with an oxygen mask at the same gas flow, especially in the simulated scenario of severe lung injury.…”